RMD · NYSE, OTC · CIK 0000943819

RESMED INC

RESMED INC’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 26, 2026. In fiscal 2026 (year ended Jun 30, 2026) it reported revenue of $5.7B and net income of $1.5B, according to its XBRL data on EDGAR. Its EDGAR record lists 59 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$5.7B
Net income, FY2026
$1.5B
Form 4 filings on record, past 12 months
59

Company overview

Legal name (as filed)
RESMED INC
Tickers
RMD, RSMDF
SEC Central Index Key (CIK)
0000943819
Business address
SAN DIEGO, CA
State or country of incorporation
DE
Fiscal year ends
June 30
SEC filer category
Large accelerated filer
Position in SEC ticker list
#413 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from RESMED INC’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$3.6BFY2022$4.2BFY2023$4.7BFY2024$5.1BFY2025$5.7BFY2026
Net income
$779.4MFY2022$897.6MFY2023$1.0BFY2024$1.4BFY2025$1.5BFY2026
RMD annual results
ItemFY2022
ended Jun 30, 2022		FY2023
ended Jun 30, 2023		FY2024
ended Jun 30, 2024		FY2025
ended Jun 30, 2025		FY2026
ended Jun 30, 2026
Revenue$3.6B$4.2B$4.7B$5.1B$5.7B
Net income$779.4M$897.6M$1.0B$1.4B$1.5B
Diluted EPS$5.30$6.09$6.92$9.51$10.43
Total assets$5.1B$6.8B$6.9B$8.2B$9.0B
Cash and equivalents$273.7M$227.9M$238.4M$1.2B$1.5B

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

RMD latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Aug 13, 202610-KAnnual report· period Jun 30, 2026Document · Index
May 1, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Sep 1, 20268-KOther events· period Aug 31, 2026Document · Index
Oct 1, 2026DEF 14ADefinitive proxy statement· period Jun 30, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about RESMED INC, by form type:

4 ×15144 ×108-K ×53 ×1ARS ×1DEFA14A ×1DEF 14A ×14/A ×110-K ×1SCHEDULE 13G ×1SCHEDULE 13G/A ×1SD ×110-Q ×1
RMD recent filings
FiledFormWhat it isOriginal
Oct 26, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 23, 2026Document · Index
Oct 23, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 8, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 7, 2026Document · Index
Oct 7, 2026144Notice of proposed sale of securitiesDocument · Index
Oct 1, 2026ARSARS· period Jun 30, 2026Document · Index
Oct 1, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Oct 1, 2026DEF 14ADefinitive proxy statement· period Jun 30, 2026Document · Index
Oct 1, 20264/AStatement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Oct 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Oct 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Oct 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Oct 1, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 14, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 8, 2026Document · Index
Sep 8, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 4, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026Document · Index
Sep 2, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 1, 20268-KOther events· period Aug 31, 2026Document · Index
Aug 17, 20268-KAuditor change; Director or officer change; Regulation FD disclosure· period Aug 13, 2026Document · Index
Aug 13, 202610-KAnnual report· period Jun 30, 2026Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026Document · Index
Aug 7, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 7, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 6, 20268-KResults of operations; Other events· period Aug 6, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 5, 2026Document · Index
Aug 5, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 7, 2026Document · Index
Jul 7, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 7, 20268-KResults of operations; Regulation FD disclosure· period Jun 30, 2026Document · Index
Jul 1, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jun 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 8, 2026Document · Index
Jun 8, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
May 27, 2026144Notice of proposed sale of securitiesDocument · Index
May 26, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 7, 2026144Notice of proposed sale of securitiesDocument · Index
May 4, 20263Initial statement of beneficial ownership· period May 4, 2026Document · Index
May 4, 20264Statement of changes in beneficial ownership (insider trade)· period May 4, 2026Document · Index
May 1, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 30, 20268-KDirector or officer change· period Apr 24, 2026Document · Index

Insider filing activity

59 Form 4 filings appear in RESMED INC’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000943819 and XBRL company facts. RESMED INC on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.